Charles River Laboratories International, Inc.’s CRL leadership in outsourced drug discovery and safety testing services supports the growth in its DSA (Discovery and Safety Assessment) segment.

Charles River expanded the Memphis facility in November 2022, adding nine processing suites to its 16 clean rooms at the site. That growth came after the facility received approval from the European ...

Apollo for CRADL is the latest in a series of innovations, integrating the Apollo technology stack across Charles River’s robust portfolio. Image Source: Zacks Investment Research Apollo for ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

TD Cowen lowered the firm’s price target on Charles River (CRL) to $179 from $182 and keeps a Hold rating on the shares. The firm updated its ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on CRL: Charles River ...

Throughout the last three months, 6 analysts have evaluated Charles River (NYSE:CRL), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...

As promised, the restructuring initiatives taking place at Charles River Labs (NYSE: CRL) have resulted in a reduced headcount at the contract research organization. As promised, the restructuring ...

WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported a loss of $215.7 million in its fourth quarter. The Wilmington ...

Acquisition of Charles River site, previously Distributed Bio ... The acquisition will provide customers in this region with a localized source of expertise and technical support, helping them ...